Kevin R. Mott

2.3k total citations
61 papers, 1.8k citations indexed

About

Kevin R. Mott is a scholar working on Epidemiology, Immunology and Oncology. According to data from OpenAlex, Kevin R. Mott has authored 61 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Epidemiology, 30 papers in Immunology and 8 papers in Oncology. Recurrent topics in Kevin R. Mott's work include Herpesvirus Infections and Treatments (49 papers), Immunotherapy and Immune Responses (16 papers) and Cytomegalovirus and herpesvirus research (16 papers). Kevin R. Mott is often cited by papers focused on Herpesvirus Infections and Treatments (49 papers), Immunotherapy and Immune Responses (16 papers) and Cytomegalovirus and herpesvirus research (16 papers). Kevin R. Mott collaborates with scholars based in United States, France and Spain. Kevin R. Mott's co-authors include Homayon Ghiasi, Steven L. Wechsler, Sariah J. Allen, Guey‐Chuen Perng, Mandana Zandian, Terrence Town, Lbachir BenMohamed, Nelson Osorio, Charles M. Perou and Clinton Jones and has published in prestigious journals such as Cell, PLoS ONE and Cancer Research.

In The Last Decade

Kevin R. Mott

60 papers receiving 1.7k citations

Peers

Countries citing papers authored by Kevin R. Mott

Since Specialization

Citations

This map shows the geographic impact of Kevin R. Mott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin R. Mott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin R. Mott more than expected).

Fields of papers citing papers by Kevin R. Mott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin R. Mott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin R. Mott. The network helps show where Kevin R. Mott may publish in the future.

Co-authorship network of co-authors of Kevin R. Mott

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin R. Mott. A scholar is included among the top collaborators of Kevin R. Mott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin R. Mott. Kevin R. Mott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Binding of herpesvirus entry mediator (HVEM) and HSV-1 gD affect reactivation but not latency levels 2023 ·PLoS Pathogens ·Ujjaldeep Jaggi, Shaohui Wang, Kevin R. Mott, Homayon Ghiasi	0
2	High-dose paclitaxel and its combination with CSF1R inhibitor in polymeric micelles for chemoimmunotherapy of triple negative breast cancer 2023 ·Nano Today ·Chaemin Lim, Duhyeong Hwang, Mostafa Yazdimamaghani, (unknown), Hyesun Hyun, (unknown), Jacob D. Ramsey, (unknown), Kevin R. Mott, Charles M. Perou, Marina Sokolsky‐Papkov, Alexander V. Kabanov	27
3	Integrated Metabolic Profiling and Transcriptional Analysis Reveals Therapeutic Modalities for Targeting Rapidly Proliferating Breast Cancers 2021 ·Cancer Research ·Chengheng Liao, Cherise Ryan Glodowski, Cheng Fan, Juan Liu, Kevin R. Mott, Akash Kaushik, Hieu Vu, Jason W. Locasale, Samuel K. McBrayer, Ralph J. DeBerardinis, Charles M. Perou, Qing Zhang	19
4	B Cells and T Follicular Helper Cells Mediate Response to Checkpoint Inhibitors in High Mutation Burden Mouse Models of Breast Cancer 2019 ·Cell ·Daniel P. Hollern, Nuo Xu, Aatish Thennavan, Cherise Ryan Glodowski, Susana García‐Recio, Kevin R. Mott, Xiaping He, Joseph P. Garay, Kelly Carey-Ewend, David Marron, (unknown), Siyao Liu, Sarah C. Vick, Miguel Martín, Joel S. Parker, Benjamin G. Vincent, Jonathan S. Serody, Charles M. Perou	307
5	The MMTV-Wnt1 murine model produces two phenotypically distinct subtypes of mammary tumors with unique therapeutic responses to an EGFR inhibitor 2019 ·Disease Models & Mechanisms ·Adam D. Pfefferle, David B. Darr, Benjamin C. Calhoun, Kevin R. Mott, Jeffrey M. Rosen, Charles M. Perou	10
6	Identification of Jun loss promotes resistance to histone deacetylase inhibitor entinostat through Myc signaling in luminal breast cancer 2018 ·Genome Medicine ·Maki Tanioka, Kevin R. Mott, Daniel P. Hollern, Cheng Fan, David B. Darr, Charles M. Perou	14
7	Batf3 deficiency is not critical for the generation of CD8α+ dendritic cells 2014 ·Immunobiology ·Kevin R. Mott, Hadi Maazi, Sariah J. Allen, Mandana Zandian, Harry H. Matundan, (unknown), Behrooz G. Sharifi, David M. Underhill, Omid Akbari, Homayon Ghiasi	14
8	Inclusion of CD80 in HSV Targets the Recombinant Virus to PD-L1 on DCs and Allows Productive Infection and Robust Immune Responses 2014 ·PLoS ONE ·Kevin R. Mott, Sariah J. Allen, Mandana Zandian, Omid Akbari, Pedram Hamrah, Hadi Maazi, Steven L. Wechsler, Arlene H. Sharpe, Gordon J. Freeman, Homayon Ghiasi	21
9	Inhibitors of signal peptide peptidase (SPP) affect HSV-1 infectivity in vitro and in vivo 2014 ·Experimental Eye Research ·Sariah J. Allen, Kevin R. Mott, Homayon Ghiasi	13
10	Binding of HSV-1 Glycoprotein K (gK) to Signal Peptide Peptidase (SPP) Is Required for Virus Infectivity 2014 ·PLoS ONE ·Sariah J. Allen, Kevin R. Mott, Yoshiharu Matsuura, Kohji Moriishi, Konstantin G. Kousoulas, Homayon Ghiasi	26
11	IL-2 Suppression of IL-12p70 by a Recombinant HSV-1 Expressing IL-2 Induces T-Cell Auto-Reactivity and CNS Demyelination 2011 ·PLoS ONE ·Mandana Zandian, Kevin R. Mott, Sariah J. Allen, Shuang Chen, Moshe Arditi, Homayon Ghiasi	12
12	Use of cytokine immunotherapy to block CNS demyelination induced by a recombinant HSV-1 expressing IL-2 2011 ·Gene Therapy ·Mandana Zandian, Kevin R. Mott, Sariah J. Allen, Oana Dumitrașcu, (unknown), Homayon Ghiasi	34
13	CD11c Controls Herpes Simplex Virus 1 Responses To Limit Virus Replication during Primary Infection 2011 ·Journal of Virology ·Sariah J. Allen, Kevin R. Mott, Aziz Alami Chentoufi, Lbachir BenMohamed, Steven L. Wechsler, Christie M. Ballantyne, Homayon Ghiasi	18
14	ICAM-5 modulates cytokine/chemokine production in the CNS during the course of herpes simplex virus type 1 infection 2009 ·Journal of Neuroimmunology ·Margaret Chui Ling Tse, (unknown), Kevin R. Mott, Nattawat Onlamoon, (unknown), Guey‐Chuen Perng	12
15	A role for the JAK-STAT1 pathway in blocking replication of HSV-1 in dendritic cells and macrophages 2009 ·Virology Journal ·Kevin R. Mott, David M. Underhill, Steven L. Wechsler, Terrence Town, Homayon Ghiasi	38
16	Epitope mapping of HSV-1 glycoprotein K (gK) reveals a T cell epitope located within the signal domain of gK 2007 ·Virus Research ·Yanira Osorio, Kevin R. Mott, Abdul Jabbar, Alberto Moreno, Timothy P. Foster, Konstantin G. Kousoulas, Homayon Ghiasi	24
17	A mutant deleted for most of the herpes simplex virus type 1 (HSV-1) UOL gene does not affect the spontaneous reactivation phenotype in rabbits 2006 ·Journal of NeuroVirology ·David C. Chan, Jacob Cohen, (unknown), Kevin R. Mott, Nelson Osorio, Ling Jin, Nigel W. Fraser, Clinton Jones, Steven L. Wechsler, Guey‐Chuen Perng	9
18	Identification of a protein encoded in the herpes simplex virus type 1 latency associated transcript promoter region 2004 ·Virus Research ·(unknown), Ruma Mukerjee, Kevin R. Mott, Wen Kang, Nelson Osorio, Nigel W. Fraser, Guey‐Chuen Perng	16
19	Glycoprotein C of herpes simplex virus type 1 is required to cause keratitis at low infectious doses in intact rabbit corneas 2004 ·Current Eye Research ·Barbara S. Drolet, Kevin R. Mott, Andrew M. Lippa, Steven L. Wechsler, Guey‐Chuen Perng	6
20	The bovine herpesvirus-1 LR ORF2 is critical for this gene's ability to restore the high wild-type reactivation phenotype to a herpes simplex virus-1 LAT null mutant 2003 ·Journal of General Virology ·Kevin R. Mott	46

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact